Consequences, opportunities and challenges of modern biotechnology for EuropeFunded under: FP7-HEALTH
Biotechnology is generally considered one of the key technologies of the 21st century, with a potentially wide range of applications in e.g. healthcare, agriculture, and industrial production processes. However, this notion has not yet been substantiated, as the diversity of sectors in which biotechnology is applied makes it difficult to investigate its actual degree of diffusion. Against this background and following a request from the European Parliament, the European Commission initiated the Biotechnology for Europe Study (Bio4EU Study). The study's objectives are to assess the contributions of modern biotechnology to the achievement of major European policy goals, and to increase public awareness and understanding of modern biotechnology. This report presents an analysis of the collected data with a view to assessing the contributions of modern biotechnology to major EU policy goals such as economic growth and job creation (Lisbon Agenda), and environmental sustainability and public health (Sustainable Development Strategy). As such, the study can be considered a background document of the Bio4EU synthesis report, which sets out the main findings of the study.
Bibliographic Reference: EUR 23413 EN (2008), various paging. Free of charge
Availability: http://bookshop.europa.eu/is-bin/INTERSHOP.enfinity/WFS/EU-Bookshop-Site/en_GB/-/EUR/ViewPublication-Start?PublicationKey=LFNA23413 (Catalogue Number: LF-NA-23413-EN-C)
ISBN: ISBN: 978-92-79-09505-4
Record Number: 200910456 / Last updated on: 2009-10-12
Original language: en
Available languages: en